NCT00252577|CompletedResultsDMC
Genetic Predictors of Lithium Response in Bipolar Disorder
Genetic Studies of Psychiatric Illness
Loading search results
Sponsor study identifier
observational
130
1 country
1
Study Start
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2016
Actual (reported)Study Completion
May 2016
Actual (reported)The purpose of this study is to identify genetic predictors of lithium response in bipolar disorder.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2016
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
November 9, 2005
Actual (reported)November 11, 2005
Actual (reported)March 2016
Actual (reported)May 2016
Actual (reported)January 29, 2020
Actual (reported)Time to Relapse
The primary outcome measure was time to relapse in months following stabilization on lithium.
every 2 months for 2 years
Veterans with bipolar disorder
Lithium is a standard treatment for bipolar disorder. Patients will be stabilized on lithium monotherapy over a 3 month period, observed for one month, and then followed every 2 months in maintenance phase for 2 years
Veterans with bipolar disorder
VA San Diego Healthcare System, San Diego, CA
San Diego, California, 92161, United States
DNA from patients with bipolar disorder
The study results are limited by small sample size and a dropout rate higher than expected.
John R Kelsoe, MD
VA San Diego Healthcare System, San Diego, CA
130 participants (actual enrollment reported by the registry).
First Submitted
November 9, 2005
First Posted
November 11, 2005
Study Start
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions
Contact the study team to confirm eligibility.
Primary Completion
March 2016
Actual (reported)Study Completion
May 2016
Actual (reported)Last Updated
January 29, 2020
Results First Posted
January 29, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: